Primary outcomes were SUDs, well-being spectrum, and mental health disorders, such as autism spectrum disorder (ASD), attention deficit/hyperactivity disorder [ADHD], posttraumatic stress disorder [PTSD], schizophrenia, bipolar disorder [BD], major depressive disorder [MDD], Tourettes syndrome, and anorexia nervosa
Your provider submits clinical documentation to your Medicaid plan for review
Sobo will discuss the treatment plan, expected timeline, dosing approach, safety considerations, and follow-up schedule
Why Inner Beauty Became So Big in Korea In Korea, the idea of beauty has been expanding from cosmetics into a broader wellness mindset
GLP-1 receptor agonist medications mimic this hormone, amplifying signals that help the body manage glucose and energy more efficiently